Literature DB >> 24201213

Enhanced oncolytic virotherapy through oxidative stress inhibition.

Kendra L Congdon1, John H Sampson.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24201213      PMCID: PMC3831049          DOI: 10.1038/mt.2013.227

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  12 in total

1.  N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy.

Authors:  Chung Kwon Kim; Atique U Ahmed; Brenda Auffinger; Ilya V Ulasov; Alex L Tobias; Kyung-Sub Moon; Maciej S Lesniak
Journal:  Mol Ther       Date:  2013-07-25       Impact factor: 11.454

Review 2.  The art of gene therapy for glioma: a review of the challenging road to the bedside.

Authors:  Alex Tobias; Atique Ahmed; Kyung-Sub Moon; Maciej S Lesniak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-09-19       Impact factor: 10.154

3.  Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

Authors:  Atique U Ahmed; Bart Thaci; Nikita G Alexiades; Yu Han; Shuo Qian; Feifei Liu; Irina V Balyasnikova; Ilya Y Ulasov; Karen S Aboody; Maciej S Lesniak
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

4.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

5.  Human neural stem cells and astrocytes, but not neurons, suppress an allogeneic lymphocyte response.

Authors:  Elisabet Akesson; Nina Wolmer-Solberg; Madeleine Cederarv; Scott Falci; Jenny Odeberg
Journal:  Stem Cell Res       Date:  2008-07-12       Impact factor: 2.020

6.  Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.

Authors:  James J Vredenburgh; Annick Desjardins; James E Herndon; Jennifer Marcello; David A Reardon; Jennifer A Quinn; Jeremy N Rich; Sith Sathornsumetee; Sridharan Gururangan; John Sampson; Melissa Wagner; Leighann Bailey; Darell D Bigner; Allan H Friedman; Henry S Friedman
Journal:  J Clin Oncol       Date:  2007-10-20       Impact factor: 44.544

7.  Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.

Authors:  Ilya V Ulasov; Zeng B Zhu; Matthew A Tyler; Yu Han; Angel A Rivera; Andrey Khramtsov; David T Curiel; Maciej S Lesniak
Journal:  Hum Gene Ther       Date:  2007-07       Impact factor: 5.695

8.  Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling.

Authors:  Jeesun Kim; Paul K Y Wong
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

Review 9.  Pharmacologic and chemical adjuvants in tumor virotherapy.

Authors:  Christopher Alvarez-Breckenridge; Balveen Kaur; E Antonio Chiocca
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 10.  Oncolytic virotherapy.

Authors:  Stephen J Russell; Kah-Whye Peng; John C Bell
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.